AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why.

In addition to landing on the IBD 50 list of growth stocks to watch. Guardant Health (GH) has also earned a spot on the Investor's Business Daily Leaderboard. And a recent approval of its Guardant360 CDx by the U.S. Food and Drug Administration have shares of the precision oncology firm testing a buy zone. Earlier this month, the FDA approved…